Recent clinical trials in diabetes - implications for managing older patients

被引：0

作者：

Hawthorne, G. C. ^{[1
]}

Yarnall, A. J. ^{[2
]}

机构：

[1] Newcastle Gen Hosp, Diabetes Ctr, Newcastle Upon Tyne, Tyne & Wear, England

[2] Freeman Rd Hosp, Dept Care Elderly, Newcastle Upon Tyne, Tyne & Wear, England

来源：

REVIEWS IN CLINICAL GERONTOLOGY | 2009年 / 19卷 / 01期

关键词：

Diabetes mellitus; elderly; glycaemic targets; microvascular disease; macrovascular disease; ypoglycaemia; cognitive function;

D O I：

10.1017/S0959259809990104

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

The prevalence of type 2 diabetes is set to increase, and with it the complications associated with diabetes. Since 2007 there have been a number of significant trials that may change the way we think about treating people with diabetes, especially our older patients. These trials include the Steno-2 trial, UKPDS legacy trial, ADVANCE, ACCORD and VADT. These trials are reviewed in detail in this article, including the implications for the patients we treat. Recent work assessing the effect of HbA1c on cognitive function and the effects of hypoglycaemia are also discussed. We conclude with suggestions for targets for glycated haemoglobin level based on NICE guidance.

引用

页码：25 / 33

页数：9

共 50 条

[41] Implications of Recent Clinical Trials in Cardiovascular Imaging on Primary Prevention Therapies
Agarwal V.
Shaw L.J.
Berman D.
Nasir K.
Rozanski A.
Blankstein R.
Current Cardiovascular Risk Reports, 2017, 11 (7)
[42] Results of recent large cholesterol - Lowering trials and implications for clinical management
Gotto, AM
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (12): : 1663 - +
[43] RECENT ADVANCES IN MANAGING THE COMPLICATIONS OF DIABETES
OMALLEY, BC
GERIATRICS, 1980, 35 (06) : 51 - 55
[44] Clinical implications of cardiovascular outcome trials in type2diabetes
Mellbin, L. G.
Wang, A.
Ryden, L.
HERZ, 2019, 44 (03) : 192 - 202
[45] ETHICAL IMPLICATIONS OF REJECTING PATIENTS FOR CLINICAL-TRIALS
CHALMERS, TC
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (06): : 865 - 865
[46] ETHICAL IMPLICATIONS OF REJECTING PATIENTS FOR CLINICAL-TRIALS
BONE, HG
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (08): : 973 - 973
[47] The clinical implications of GAD antibody positivity in older patients with established non-insulin requiring diabetes
Hitman, G. A.
Hawa, M. I.
Leslie, R. D. G.
Ola, T.
Wun, C. -C.
DeMicco, D.
Betteridge, D. J.
Durrington, P. N.
Fuller, J. H.
Neil, H. A. W.
Colhoun, H. M.
DIABETOLOGIA, 2008, 51 : S230 - S231
[48] Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials
Karasik, Avraham
Aschner, Pablo
Katzeff, Harvey
Davies, Michael J.
Stein, Peter P.
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (02) : 489 - 496
[49] Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials
Reboldi, Gianpaolo
Gentile, Giorgio
Angeli, Fabio
Verdecchia, Paolo
VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 : 411 - 427
[50] Testosterone and the prevention of type 2 diabetes mellitus: therapeutic implications from recent trials
Wittert, Gary
Umapathysivam, Mahesh M.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2024, 31 (06) : 243 - 248

← 1 2 3 4 5 →